Hospice Coverage Expansion: Beijing will add palliative care to basic medical insurance starting July 11, with a unified 200 yuan/day hospice rate covered under Class A payments—aimed at easing a major end-of-life care supply gap. Ebola Response Boost: WHO is intensifying Ebola-curbing efforts in the DRC with the PARTNERS trial, testing antiviral therapies (including remdesivir) and rolling out diagnostic tests as deaths from a new Bundibugyo strain climb. Cancer Immunotherapy Advances: Chinese teams report progress in safer, feeder-free TIL expansion using lower IL-2, plus a new breast cancer classification system that predicts immunotherapy response via a cancer-immunity-cycle score. Biotech Growth in the Greater Bay Area: Guangdong’s Greater Bay Area biotech push is highlighted through Akeso’s rapid drug-discovery and manufacturing scale-up, alongside claims of strong clinical performance and a growing pipeline. Hospitals & Public Health Cooperation: China continues deploying medical teams to Botswana and sending a second expert group to the DRC for Ebola prevention, lab work, case treatment, and infection control. Controversial Medical Trade Allegation: Pakistan’s FIA says it uncovered a human placenta smuggling network, including Chinese nationals, allegedly tied to “anti-ageing” injections—raising new scrutiny of placenta sourcing and processing. Health Tech Access: China expands brain-computer interface coverage under its healthcare system, supporting mobility for patients with paralysis and ALS.